Consider an illustrative patient with a history of anxiety who presents with a pounding heart. A resting pulse of 118, unintentional weight loss, heat intolerance, tremor, and a diffusely enlarged thyroid deserve an endocrine explanation—not an assumption that this is panic. An ECG showing sinus tachycardia identifies the rhythm at that moment; it does not identify the cause.
Suppose the initial TSH returns below 0.01 mU/L. The important next question is not just whether thyroid hormone is involved. It is whether the gland is making too much hormone or releasing stored hormone from damaged tissue. That distinction can determine whether methimazole helps at all.
Confirm the hormone pattern before naming the cause
A suppressed TSH is a signal to check thyroid hormone levels, not proof of Graves disease. Measure free T4 and T3; a normal free T4 does not exclude excess hormone if T3 is elevated. If both are within the reference range, the pattern is consistent with subclinical hyperthyroidism. Confirm that TSH suppression persists and consider the clinical context before making treatment decisions.
Then look for the source. In this illustrative patient, a firm, diffuse goiter and lid lag make Graves disease plausible, but they do not establish it. Lid lag can accompany thyrotoxicosis without Graves eye disease; true proptosis, eye inflammation, or double vision is more suggestive of thyroid eye involvement. Ask about recent pregnancy, thyroid or weight-loss products, supplements such as biotin, iodine exposure, and medications that can affect the thyroid or test results.
TRAb or TSI can support Graves disease. If the cause remains unclear, radioactive iodine uptake can help distinguish active hormone synthesis from destructive thyroiditis: uptake is generally increased in Graves or toxic nodular disease and low in destructive thyroiditis. Pregnancy and breastfeeding status matter before uptake testing, and recent iodine exposure can lower uptake and complicate interpretation.
The treatment fork: synthesis or leakage
The symptoms can look similar, but the mechanism differs. In Graves disease and toxic nodular disease, the thyroid is actively producing excess hormone. In destructive thyroiditis, damaged cells release hormone already stored in the gland. Methimazole reduces new hormone synthesis; it does not stop stored hormone from leaking out.
| Likely process | Clues that can help | Treatment implication |
|---|---|---|
| Graves disease | TRAb/TSI supports the diagnosis; a symmetric goiter or Graves eye disease may add support; uptake is typically diffuse and increased | Antithyroid medication can reduce new hormone production when clinically appropriate. |
| Toxic nodule or multinodular disease | One or more nodules may be present; uptake may be focal or patchy | This is also excess synthesis, so thionamides may control production; the longer-term plan depends on the cause and patient. |
| Destructive thyroiditis | Thyroid pain can occur in subacute thyroiditis, but painless forms also occur; uptake is typically low during the thyrotoxic phase | Symptom relief may be appropriate, but antithyroid medication does not address the release of stored hormone. |
These are patterns, not stand-alone diagnostic rules. A nontender thyroid does not exclude thyroiditis, and a diffuse goiter does not by itself prove Graves disease. When examination, labs, and antibody testing do not settle the cause, use the appropriate next test or specialist support rather than treating the suppressed TSH as the diagnosis.
Separate symptom relief from disease-directed treatment
While the cause is being clarified, symptom control is a separate decision. A beta-blocker may reduce palpitations, tremor, and tachycardia in a symptomatic patient, even before the cause is known, but it does not lower thyroid hormone levels. Review blood pressure, comorbidities, pregnancy possibility, and contraindications before choosing one; arrange follow-up to reassess symptoms and the laboratory pattern.
A pulse of 118 deserves attention, but that number alone does not diagnose thyroid storm or determine disposition. Reassess vital signs and the patient’s overall condition. New chest pain, syncope, an irregular rhythm, heart-failure signs, hemodynamic instability, high fever, or altered mental status should shift the plan to urgent emergency assessment. If thyroid storm is suspected, do not wait for confirmatory thyroid tests before escalating care.
For a patient with overt thyrotoxicosis and a convincing Graves pattern, antithyroid treatment may be appropriate; the plan should reflect clinical severity and specialist input. Before starting methimazole, obtain a baseline CBC with differential and liver profile. Counsel the patient to stop the medication and contact a clinician promptly if fever or sore throat develops, or if symptoms suggest liver injury, such as jaundice or dark urine. The practical safeguard remains: do not prescribe methimazole solely because TSH is suppressed, especially when the cause has not been considered.
Common shortcuts to avoid
- “Low TSH means Graves.” It establishes neither the hormone level nor the etiology.
- “A beta-blocker treats the thyroid.” It can ease adrenergic symptoms; it does not stop hormone production or leakage.
- “Any thyrotoxicosis needs methimazole.” It helps when excess synthesis is the problem, not when stored hormone is leaking from an inflamed gland.
- “No thyroid pain means no thyroiditis.” Some forms are painless.
- “Sinus tachycardia settles the case.” It identifies the rhythm on that ECG, not the underlying cause or future rhythm.
Practical takeaways
- With suppressed TSH, check free T4 and T3 before labeling the biochemical state.
- Separate excess hormone production from hormone release; the distinction changes whether methimazole can help.
- Use TRAb/TSI and, when appropriate, uptake testing to clarify etiology; treat examination findings as clues, not proof.
- Consider symptom control separately from cause-directed treatment, and escalate urgently for instability or features concerning for thyroid storm.
